Sunday, 5 July 2026European Markets

#pharmaceutical innovation

1 article

GSK targets late 2027 launch for Depemokimab ultra-long-acting biologic

European Pharma Innovation

GSK targets late 2027 launch for Depemokimab ultra-long-acting biologic

ViaNews Editorial Team (Europe)•Feb 21, 2026